351 related articles for article (PubMed ID: 8892923)
1. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
[TBL] [Abstract][Full Text] [Related]
2. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
Mathys L; François KO; Quandte M; Braakman I; Balzarini J
PLoS One; 2014; 9(6):e101181. PubMed ID: 24967714
[TBL] [Abstract][Full Text] [Related]
4. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
6. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
7. Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.
Tani Y; Donoghue E; Sharpe S; Boone E; Lane HC; Zolla-Pazner S; Cohen DI
J Virol; 1994 Mar; 68(3):1942-50. PubMed ID: 8107254
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
Bour S; Boulerice F; Wainberg MA
J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
[TBL] [Abstract][Full Text] [Related]
9. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.
Ivey-Hoyle M; Clark RK; Rosenberg M
J Virol; 1991 May; 65(5):2682-5. PubMed ID: 2016774
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
Bandres JC; Wang QF; O'Leary J; Baleaux F; Amara A; Hoxie JA; Zolla-Pazner S; Gorny MK
J Virol; 1998 Mar; 72(3):2500-4. PubMed ID: 9499113
[TBL] [Abstract][Full Text] [Related]
12. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
13. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
[TBL] [Abstract][Full Text] [Related]
14. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
San José E; Muñoz-Fernández MA; Alarcón B
Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
[TBL] [Abstract][Full Text] [Related]
15. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.
Bahbouhi B; Bendjennat M; Guétard D; Seidah NG; Bahraoui E
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):91-8. PubMed ID: 11062061
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
Thali M; Furman C; Helseth E; Repke H; Sodroski J
J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Ashorn P; Berger EA; Moss B
Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
[No Abstract] [Full Text] [Related]
18. Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160.
Polpitiya Arachchige S; Henke W; Pramanik A; Kalamvoki M; Stephens EB
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093081
[TBL] [Abstract][Full Text] [Related]
19. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.
Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J
Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
Willey RL; Maldarelli F; Martin MA; Strebel K
J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
